Skip to main content Accessibility help
×
Home
  • Print publication year: 2012
  • Online publication date: February 2013

Chapter 22 - The future

from Section 2 - Fetal disease

Summary

This chapter talks about the Global Obstetrics Network (GONet) mission, its collaborators, structure and function, and plans for the future. The GONet mission will provide insight and camaraderie, cooperate on data elements to allow future collaborations, and identify and highlight the pressing issues in maternal-fetal medicine. The collaborative networks initiated in the USA, the UK and Canada inspired clinicians and researchers in other countries to start similar initiatives. The groups collaborating in GONet include: Maternal-Fetal Medicine Units Network (NICHD), Maternal-fetal medicine research, the NIHR Comprehensive Local Research Network, Dutch Obstetric Research Consortium and Hong Kong Maternal-Fetal Medicine Network. The collaboration will also facilitate new forms of meta-analysis, such as prospective meta-analysis and individual patient data meta-analysis. The board also includes a representative from PREBIC, the international consortium to prevent preterm birth, as well as liaisons with the World Health Organization (WHO) and the Cochrane collaboration.
References
Altman, DG. Better reporting of randomised controlled trials: the CONSORT statement. BMJ 1996;313:5701.
Pocock, SJ. Clinical Trials: A Practical Approach. Chichester, Wiley, 1983.
Senn, S. Statistical Issues in Drug Development. Chichester, Wiley, 1997.
Kenyon, SL, Taylor, DJ, Tarnow-Mordi, W; ORACLE Collaborative Group. Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. ORACLE Collaborative Group. Lancet 2001;357:989–94.
Kenyon, SL, Taylor, DJ, Tarnow-Mordi, W; ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001;357:979–88.
Hills, RK, Daniels, J. Assessing new interventions in women’s health. Best Pract Res Clin Obstet Gynaecol 2006;20:713–28.
Lasagna, L. Problems in publication of clinical trial methodology. Clin Pharmacol Ther 1979;25:751–3.
Raza, A, Chien, PF, Khan, KS. Multicentre randomised controlled trials in obstetrics and gynaecology: an analysis of trends over three decades. BJOG 2009;116:1130–4.
Kuroki, LM, Allsworth, JE, Peipert, JF. Methodology and analytic techniques used in clinical research: associations with journal impact factor. Obstet Gynecol 2009;114(4):877–84.
Thom, EA, Rouse, DJ; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned about conducting randomized controlled trials in the NICHD MFMU network. Semin Perinatol 2003;27:253–60.
Hannah, ME, Hannah, WJ, Hewson, SA, et al. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group. Lancet 2000;356:1375–83.
Poston, L, Briley, AL, Seed, PT, Kelly, FJ, Shennan, AH; Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367:1145–54.
Norman, JE, Mackenzie, F, Owen, P, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009;373(9680):2034–40.
Shennan, AH, Crawshaw, S, Briley, A, et al. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervico-vaginal fetal fibronectin: the PREMET Study. BJOG 2006;113:65–74.
Groom, KM, Shennan, AH, Jones, BA, Seed, P, Bennett, P. Randomised double blind placebo controlled trial of rofecoxib (a cox-2 specific prostaglandin inhibitor) for the prevention of preterm delivery in women at high risk. BJOG 2005;112(6):725–30.
Comparative Obstetric Mobile Epidural Trial (COMET) Study Group UK. Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a randomised controlled trial. Lancet 2001;358:19–23.
Fisk, NM, Atun, R. Market failure and the poverty of new drugs in maternal health. PLoS Med 2008;5:e22.
Wapner, RJ Sorokin, Y, Mele, L, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine units Network. Long-term outcomes after repeat doses of antenatal cortiosteriods. N Engl J Med 2007;357:1190–8.
Meis, PJ, Klebanoff, M, Thom, E, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine units Network. Prevention of recurrent preterm delivery by 17-alpha hydroxyprogestrone caproate. N Engl J Med 2003;348:2379–85.
Lamdon, MB, Hauth, JC, Leveno, KJ, et al. National Institute of Child Health and Human Development Maternal-Fetal Medicine units Network. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004;351:2581–90.
Magee, LA, von Dadelszen, P, Chan, S, et al. The Control of Hypertension in Pregnancy Study pilot trial. BJOG 2007;114:13–20.
Murphy, KE, Hannah, ME, Willan, AR, et al. Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 2008 ;372:2143–51.
Bakker, JJH, Verhoeven, C, Janssen, P, et al. Does internal tocodynamometry improve the outcome of labour? A randomised controlled trial comparing monitoring of contractions with an intrauterine pressure catheter to an external tocotransducer during induced or augmented labor. N Engl J Med 2010;362:306–13.
Koopmans, CM, Bijlenga, D, Aarnoudse, JG, et al. Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. Lancet 2009;374:979–88.
Mol, BW, Ruifroth, AE, for the Global obstetrics Network. Global adjustment, coordination and collaboration in perinatal research: The Global obstetrics Network (GONet initiative. Aa J Perinatol 2012: in press.